Publications To Date


    Filter Publications

    PAGE 65 OF 73 | DISPLAYING 961 - 975 OF 1088 RESULTS

    Ramaswamy V. et al., Duration of the pre-diagnostic interval in medulloblastoma is subgroup dependent., [Epub ahead of print]., Pediatr Blood Cancer., Feb 25, 2014

    Brooks S.A et al., ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma., [Epub ahead of print]., European Urology, Feb 25, 2014

    Sivendran S. et al., Dissection of immune gene networks in primary melanoma tumors critical for anti-tumor surveillance of patients with stage II-III resectable disease., [Epub ahead of print]., Journal of Investigative Dermatology , Feb 12, 2014

    Filipits M. et al., The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer., [Epub ahead of print]., Clin. Cancer Res., Feb 11, 2014

    Gasparini P. et al., Androgen receptor status Is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options., [Epub ahead of print]., PLoS ONE, Feb 05, 2014

    Fang D.D. et al., HIP1-ALK, A Novel ALK Fusion Variant that Responds to Crizotinib., [Epub ahead of print]., J Thorac Oncol., Feb 03, 2014

    Balko J.M. et al., Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets., 4:232 - 245., Cancer Discovery, Feb 01, 2014

    Riester M. et al., Integrative analysis of 1q23.3 copy number gain in metastatic urothelial carcinoma., [Epub ahead of print]., Clin. Cancer Res., Jan 31, 2014

    Stricker T.P. et al., Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounterâ„¢ system., [Epub ahead of print]., Molecular Oncology, Jan 31, 2014

    Kojima K. et al., Transcriptome profiling of archived sectioned Formalin-Fixed Paraffin-Embedded (AS-FFPE) tissue for disease classification., [Epub ahead of print]., PLoS ONE, Jan 30, 2014

    Pastori C. et al., BET bromodomain proteins are required for glioblastoma cell proliferation., [Epub ahead of print]., Epigenetics, Jan 17, 2014

    Ullal A.V. et al., Cancer cell profiling by barcoding allows multiplexed protein analysis in fine-needle aspirates., 6(219): 219ra9, Sci Trans. Med., Jan 15, 2014

    Sikora M.J. et al., Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response., [Epub ahead of print]., Cancer Res., Jan 14, 2014

    Cui W. et al., Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma., [Epub ahead of print]., J. Trans. Med., Jan 13, 2014

    Park S. et al., Aberrant CDK4 amplification in refractory Rhabdomyosarcoma as identified by genomic profiling., [Epub ahead of print]., Sci Rep., Jan 10, 2014